▶ 調査レポート

世界の二次性副甲状腺機能亢進症の治療市場：市場規模・現状・予測
• 英文タイトル：Global Secondary Hyperparathyroidism Treatment Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の二次性副甲状腺機能亢進症の治療市場：市場規模・現状・予測 / Global Secondary Hyperparathyroidism Treatment Market Size, Status and Forecast 2019-2025 / QYR9N8010資料のイメージです。• レポートコード：QYR9N8010
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、二次性副甲状腺機能亢進症の治療のグローバル市場について調査・分析したレポートで、種類別（手術、薬物、ビタミンD、カルシミメティクス、リン酸塩バインダー）、用途別（病院薬局、小売薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・二次性副甲状腺機能亢進症の治療の世界市場規模
・主要企業別市場シェア
・二次性副甲状腺機能亢進症の治療の世界市場規模：種類別（手術、薬物、ビタミンD、カルシミメティクス、リン酸塩バインダー）
・二次性副甲状腺機能亢進症の治療の世界市場規模：用途別（病院薬局、小売薬局）
・二次性副甲状腺機能亢進症の治療のアメリカ市場規模（種類別、用途別）
・二次性副甲状腺機能亢進症の治療のヨーロッパ市場規模（種類別、用途別）
・二次性副甲状腺機能亢進症の治療の中国市場規模（種類別、用途別）
・二次性副甲状腺機能亢進症の治療の日本市場規模（種類別、用途別）
・二次性副甲状腺機能亢進症の治療の東南アジア市場規模（種類別、用途別）
・二次性副甲状腺機能亢進症の治療のインド市場規模（種類別、用途別）
・二次性副甲状腺機能亢進症の治療の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・二次性副甲状腺機能亢進症の治療の世界市場予測（2019年-2025年）
・二次性副甲状腺機能亢進症の治療の地域別市場予測（2019年-2025年）
...

Secondary hyperparathyroidism refers to the excessive secretion of parathyroid hormone by the parathyroid glands in response to hypocalcemia and associated hyperplasia of the glands.In the treatment of secondary hyperparathyroidism due to chronic kidney disease on dialysis calcimimetics do not appear to affect the risk of early death. It does decrease the need for a parathyroidectomy but caused more issues with low blood calcium levels and vomiting.
In 2018, the global Secondary Hyperparathyroidism Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Secondary Hyperparathyroidism Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Secondary Hyperparathyroidism Treatment development in United States, Europe and China.

The key players covered in this study
Amgen
OPKO Health
AbbVie
Astellas Pharma
Roche
KAI Pharmaceuticals
Kyowa Hakko Kirin
Leo Pharma
Shire
Sanofi
Deltanoid Pharmaceuticals

Market segment by Type, the product can be split into
Surgery
Drugs
Vitamin D
Calcimimetics
Phosphate Binders

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Secondary Hyperparathyroidism Treatment status, future forecast, growth opportunity, key market and key players.
To present the Secondary Hyperparathyroidism Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Secondary Hyperparathyroidism Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Secondary Hyperparathyroidism Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Surgery
1.4.3 Drugs
1.4.4 Vitamin D
1.4.5 Calcimimetics
1.4.6 Phosphate Binders
1.5 Market by Application
1.5.1 Global Secondary Hyperparathyroidism Treatment Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Secondary Hyperparathyroidism Treatment Market Size
2.2 Secondary Hyperparathyroidism Treatment Growth Trends by Regions
2.2.1 Secondary Hyperparathyroidism Treatment Market Size by Regions (2014-2025)
2.2.2 Secondary Hyperparathyroidism Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Secondary Hyperparathyroidism Treatment Market Size by Manufacturers
3.1.1 Global Secondary Hyperparathyroidism Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Secondary Hyperparathyroidism Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Secondary Hyperparathyroidism Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Secondary Hyperparathyroidism Treatment Key Players Head office and Area Served
3.3 Key Players Secondary Hyperparathyroidism Treatment Product/Solution/Service
3.4 Date of Enter into Secondary Hyperparathyroidism Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Secondary Hyperparathyroidism Treatment Market Size by Type (2014-2019)
4.2 Global Secondary Hyperparathyroidism Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Secondary Hyperparathyroidism Treatment Market Size (2014-2019)
5.2 Secondary Hyperparathyroidism Treatment Key Players in United States
5.3 United States Secondary Hyperparathyroidism Treatment Market Size by Type
5.4 United States Secondary Hyperparathyroidism Treatment Market Size by Application

6 Europe
6.1 Europe Secondary Hyperparathyroidism Treatment Market Size (2014-2019)
6.2 Secondary Hyperparathyroidism Treatment Key Players in Europe
6.3 Europe Secondary Hyperparathyroidism Treatment Market Size by Type
6.4 Europe Secondary Hyperparathyroidism Treatment Market Size by Application

7 China
7.1 China Secondary Hyperparathyroidism Treatment Market Size (2014-2019)
7.2 Secondary Hyperparathyroidism Treatment Key Players in China
7.3 China Secondary Hyperparathyroidism Treatment Market Size by Type
7.4 China Secondary Hyperparathyroidism Treatment Market Size by Application

8 Japan
8.1 Japan Secondary Hyperparathyroidism Treatment Market Size (2014-2019)
8.2 Secondary Hyperparathyroidism Treatment Key Players in Japan
8.3 Japan Secondary Hyperparathyroidism Treatment Market Size by Type
8.4 Japan Secondary Hyperparathyroidism Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Secondary Hyperparathyroidism Treatment Market Size (2014-2019)
9.2 Secondary Hyperparathyroidism Treatment Key Players in Southeast Asia
9.3 Southeast Asia Secondary Hyperparathyroidism Treatment Market Size by Type
9.4 Southeast Asia Secondary Hyperparathyroidism Treatment Market Size by Application

10 India
10.1 India Secondary Hyperparathyroidism Treatment Market Size (2014-2019)
10.2 Secondary Hyperparathyroidism Treatment Key Players in India
10.3 India Secondary Hyperparathyroidism Treatment Market Size by Type
10.4 India Secondary Hyperparathyroidism Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Secondary Hyperparathyroidism Treatment Market Size (2014-2019)
11.2 Secondary Hyperparathyroidism Treatment Key Players in Central & South America
11.3 Central & South America Secondary Hyperparathyroidism Treatment Market Size by Type
11.4 Central & South America Secondary Hyperparathyroidism Treatment Market Size by Application

12 International Players Profiles
12.1 Amgen
12.1.1 Amgen Company Details
12.1.2 Company Description and Business Overview
12.1.3 Secondary Hyperparathyroidism Treatment Introduction
12.1.4 Amgen Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019)
12.1.5 Amgen Recent Development
12.2 OPKO Health
12.2.1 OPKO Health Company Details
12.2.2 Company Description and Business Overview
12.2.3 Secondary Hyperparathyroidism Treatment Introduction
12.2.4 OPKO Health Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019)
12.2.5 OPKO Health Recent Development
12.3 AbbVie
12.3.1 AbbVie Company Details
12.3.2 Company Description and Business Overview
12.3.3 Secondary Hyperparathyroidism Treatment Introduction
12.3.4 AbbVie Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019)
12.3.5 AbbVie Recent Development
12.4 Astellas Pharma
12.4.1 Astellas Pharma Company Details
12.4.2 Company Description and Business Overview
12.4.3 Secondary Hyperparathyroidism Treatment Introduction
12.4.4 Astellas Pharma Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019)
12.4.5 Astellas Pharma Recent Development
12.5 Roche
12.5.1 Roche Company Details
12.5.2 Company Description and Business Overview
12.5.3 Secondary Hyperparathyroidism Treatment Introduction
12.5.4 Roche Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019)
12.5.5 Roche Recent Development
12.6 KAI Pharmaceuticals
12.6.1 KAI Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Secondary Hyperparathyroidism Treatment Introduction
12.6.4 KAI Pharmaceuticals Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019)
12.6.5 KAI Pharmaceuticals Recent Development
12.7 Kyowa Hakko Kirin
12.7.1 Kyowa Hakko Kirin Company Details
12.7.2 Company Description and Business Overview
12.7.3 Secondary Hyperparathyroidism Treatment Introduction
12.7.4 Kyowa Hakko Kirin Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019)
12.7.5 Kyowa Hakko Kirin Recent Development
12.8 Leo Pharma
12.8.1 Leo Pharma Company Details
12.8.2 Company Description and Business Overview
12.8.3 Secondary Hyperparathyroidism Treatment Introduction
12.8.4 Leo Pharma Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019)
12.8.5 Leo Pharma Recent Development
12.9 Shire
12.9.1 Shire Company Details
12.9.2 Company Description and Business Overview
12.9.3 Secondary Hyperparathyroidism Treatment Introduction
12.9.4 Shire Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019)
12.9.5 Shire Recent Development
12.10 Sanofi
12.10.1 Sanofi Company Details
12.10.2 Company Description and Business Overview
12.10.3 Secondary Hyperparathyroidism Treatment Introduction
12.10.4 Sanofi Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019)
12.10.5 Sanofi Recent Development
12.11 Deltanoid Pharmaceuticals

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Secondary Hyperparathyroidism Treatment Key Market Segments
Table Key Players Secondary Hyperparathyroidism Treatment Covered
Table Global Secondary Hyperparathyroidism Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Secondary Hyperparathyroidism Treatment Market Size Market Share by Type 2014-2025
Figure Surgery Figures
Table Key Players of Surgery
Figure Drugs Figures
Table Key Players of Drugs
Figure Vitamin D Figures
Table Key Players of Vitamin D
Figure Calcimimetics Figures
Table Key Players of Calcimimetics
Figure Phosphate Binders Figures
Table Key Players of Phosphate Binders
Table Global Secondary Hyperparathyroidism Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Secondary Hyperparathyroidism Treatment Report Years Considered
Table Global Secondary Hyperparathyroidism Treatment Market Size 2014-2025 (Million US$)
Figure Global Secondary Hyperparathyroidism Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Secondary Hyperparathyroidism Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Secondary Hyperparathyroidism Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Secondary Hyperparathyroidism Treatment Market Share by Regions 2014-2019
Figure Global Secondary Hyperparathyroidism Treatment Market Share by Regions 2014-2019
Figure Global Secondary Hyperparathyroidism Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Secondary Hyperparathyroidism Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Secondary Hyperparathyroidism Treatment Market Share by Manufacturers (2014-2019)
Figure Global Secondary Hyperparathyroidism Treatment Market Share by Manufacturers in 2018
Table Global Secondary Hyperparathyroidism Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Secondary Hyperparathyroidism Treatment Product/Solution/Service
Table Date of Enter into Secondary Hyperparathyroidism Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Secondary Hyperparathyroidism Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Secondary Hyperparathyroidism Treatment Market Size Share by Type (2014-2019)
Figure Global Secondary Hyperparathyroidism Treatment Market Size Market Share by Type (2014-2019)
Table Global Secondary Hyperparathyroidism Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Secondary Hyperparathyroidism Treatment Market Size Share by Application (2014-2019)
Figure Global Secondary Hyperparathyroidism Treatment Market Size Market Share by Application (2014-2019)
Figure Global Secondary Hyperparathyroidism Treatment Revenue Market Share by Application in 2018
Figure United States Secondary Hyperparathyroidism Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Secondary Hyperparathyroidism Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Secondary Hyperparathyroidism Treatment Market Share (2018-2019)
Table United States Secondary Hyperparathyroidism Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Secondary Hyperparathyroidism Treatment Market Share by Type (2014-2019)
Table United States Secondary Hyperparathyroidism Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Secondary Hyperparathyroidism Treatment Market Share by Application (2014-2019)
Figure Europe Secondary Hyperparathyroidism Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Secondary Hyperparathyroidism Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Secondary Hyperparathyroidism Treatment Market Share (2018-2019)
Table Europe Secondary Hyperparathyroidism Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Secondary Hyperparathyroidism Treatment Market Share by Type (2014-2019)
Table Europe Secondary Hyperparathyroidism Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Secondary Hyperparathyroidism Treatment Market Share by Application (2014-2019)
Figure China Secondary Hyperparathyroidism Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Secondary Hyperparathyroidism Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Secondary Hyperparathyroidism Treatment Market Share (2018-2019)
Table China Secondary Hyperparathyroidism Treatment Market Size by Type (2014-20189) (Million US$)
Table China Secondary Hyperparathyroidism Treatment Market Share by Type (2014-2019)
Table China Secondary Hyperparathyroidism Treatment Market Size by Application (2014-2019) (Million US$)
Table China Secondary Hyperparathyroidism Treatment Market Share by Application (2014-2019)
Figure Japan Secondary Hyperparathyroidism Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Secondary Hyperparathyroidism Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Secondary Hyperparathyroidism Treatment Market Share (2018-2019)
Table Japan Secondary Hyperparathyroidism Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Secondary Hyperparathyroidism Treatment Market Share by Type (2014-2019)
Table Japan Secondary Hyperparathyroidism Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Secondary Hyperparathyroidism Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Secondary Hyperparathyroidism Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Secondary Hyperparathyroidism Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Secondary Hyperparathyroidism Treatment Market Share (2018-2019)
Table Southeast Asia Secondary Hyperparathyroidism Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Secondary Hyperparathyroidism Treatment Market Share by Type (2014-2019)
Table Southeast Asia Secondary Hyperparathyroidism Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Secondary Hyperparathyroidism Treatment Market Share by Application (2014-2019)
Figure India Secondary Hyperparathyroidism Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Secondary Hyperparathyroidism Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Secondary Hyperparathyroidism Treatment Market Share (2018-2019)
Table India Secondary Hyperparathyroidism Treatment Market Size by Type (2014-2019) (Million US$)
Table India Secondary Hyperparathyroidism Treatment Market Share by Type (2014-2019)
Table India Secondary Hyperparathyroidism Treatment Market Size by Application (2014-2019) (Million US$)
Table India Secondary Hyperparathyroidism Treatment Market Share by Application (2014-2019)
Figure Central & South America Secondary Hyperparathyroidism Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Secondary Hyperparathyroidism Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Secondary Hyperparathyroidism Treatment Market Share (2018-2019)
Table Central & South America Secondary Hyperparathyroidism Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Secondary Hyperparathyroidism Treatment Market Share by Type (2014-2019)
Table Central & South America Secondary Hyperparathyroidism Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Secondary Hyperparathyroidism Treatment Market Share by Application (2014-2019)
Table Amgen Company Details
Table Amgen Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019) (Million US$)
Figure Amgen Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2014-2019)
Table Amgen Recent Development
Table OPKO Health Company Details
Table OPKO Health Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019)(Million US$)
Figure OPKO Health Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2014-2019)
Table OPKO Health Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2014-2019)
Table AbbVie Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019)(Million US$)
Figure Astellas Pharma Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2014-2019)
Table Astellas Pharma Recent Development
Table Roche Company Details
Table Roche Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2014-2019)
Table Roche Recent Development
Table KAI Pharmaceuticals Company Details
Table KAI Pharmaceuticals Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019)(Million US$)
Figure KAI Pharmaceuticals Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2014-2019)
Table KAI Pharmaceuticals Recent Development
Table Kyowa Hakko Kirin Company Details
Table Kyowa Hakko Kirin Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019)(Million US$)
Figure Kyowa Hakko Kirin Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2014-2019)
Table Kyowa Hakko Kirin Recent Development
Table Leo Pharma Company Details
Table Leo Pharma Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019)(Million US$)
Figure Leo Pharma Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2014-2019)
Table Leo Pharma Recent Development
Table Shire Company Details
Table Shire Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019)(Million US$)
Figure Shire Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2014-2019)
Table Shire Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2014-2019)
Table Sanofi Recent Development
Table Deltanoid Pharmaceuticals Company Details
Table Global Secondary Hyperparathyroidism Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Secondary Hyperparathyroidism Treatment Market Size Share by Regions (2019-2025)
Figure Global Secondary Hyperparathyroidism Treatment Market Size Share by Regions in 2025
Figure United States Secondary Hyperparathyroidism Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Secondary Hyperparathyroidism Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Secondary Hyperparathyroidism Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Secondary Hyperparathyroidism Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Secondary Hyperparathyroidism Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Secondary Hyperparathyroidism Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Secondary Hyperparathyroidism Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Secondary Hyperparathyroidism Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Secondary Hyperparathyroidism Treatment Market Size by Product (2019-2025)
Figure Global Secondary Hyperparathyroidism Treatment Market Size by Product in 2025
Table Global Secondary Hyperparathyroidism Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Secondary Hyperparathyroidism Treatment Market Size by Application (2019-2025)
Figure Global Secondary Hyperparathyroidism Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の腱炎治療市場：市場規模・現状・予測
    Global Tendinitis Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8111 2019年6月14日 93Pages
    当資料は、腱炎治療のグローバル市場について調査・分析したレポートで、種類別（薬、手術療法、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・腱炎治療...
  • 世界のポロ角化症の治療市場：市場規模・現状・予測
    Global Porokeratosis Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7861 2019年6月14日 109Pages
    当資料は、ポロ角化症の治療のグローバル市場について調査・分析したレポートで、種類別（薬、光線力学療法、凍結療法、レーザー、その他）、用途別（病院、診療所、診断センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれて...
  • 世界の感覚異常の治療市場：市場規模・現状・予測
    Global Paresthesia Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7765 2019年6月14日 96Pages
    当資料は、感覚異常の治療のグローバル市場について調査・分析したレポートで、種類別（急性感覚異常、慢性感覚異常）、用途別（病院、診療所、診断センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の髄膜炎菌感染症の治療市場：市場規模・現状・予測
    Global Meningococcal Infections Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7541 2019年6月14日 94Pages
    当資料は、髄膜炎菌感染症の治療のグローバル市場について調査・分析したレポートで、種類別（抗生物質、グルココルチコイド、プロテインC濃縮物）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています...
  • 世界の下垂体の治療市場：市場規模・現状・予測
    Global Hypodontia Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7329 2019年6月14日 93Pages
    当資料は、下垂体の治療のグローバル市場について調査・分析したレポートで、種類別（修復歯科、歯列矯正、口腔外科、その他）、用途別（病院、歯科医院、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
    <...
  • 世界のHIVの診断と治療市場：市場規模・現状・予測
    Global HIV Diagnosis and Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7303 2019年6月14日 95Pages
    当資料は、HIVの診断と治療のグローバル市場について調査・分析したレポートで、種類別（抗体検査、ウイルス同定アッセイ、Cd4テスト、ウイルス負荷試験、早期乳児診断）、用途別（診断研究所、病院、血液銀行、在宅ケアの設定）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場...
  • 世界の汗腺炎掻爬治療市場：市場規模・現状・予測
    Global Hidradenitis Suppurativa Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7295 2019年6月14日 99Pages
    当資料は、汗腺炎掻爬治療のグローバル市場について調査・分析したレポートで、種類別（薬、手術、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・汗腺炎...
  • 世界のフォンヴィレブランド病治療市場：市場規模・現状・予測
    Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8188 2019年6月14日 93Pages
    当資料は、フォンヴィレブランド病治療のグローバル市場について調査・分析したレポートで、種類別（ヴェイヴォンディ、フミン酸-P、英数字、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...
  • 世界のディンプル形成術の治療市場：市場規模・現状・予測
    Global Dimpleplasty Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7109 2019年6月14日 93Pages
    当資料は、ディンプル形成術の治療のグローバル市場について調査・分析したレポートで、種類別（光線療法、レーザー治療、その他）、用途別（病院、皮膚科クリニック、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界のサイトメガロウイルス治療市場：市場規模・現状・予測
    Global Cytomegalovirus Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7060 2019年6月14日 97Pages
    当資料は、サイトメガロウイルス治療のグローバル市場について調査・分析したレポートで、種類別（ガンシクロビル、バルガンシクロビル、フォスカーネット、シドフォビル、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模...